Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Cervical Spinal Cord Injury with Imatinib
2014-002170-36Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in cervical spinal cord injury, sponsored by Karolinska University Hospital. Primary endpoints: Plasma Imatinib Levels and Change in Serum Cytokines. Started Dec 2014; status: active.
02
Drugs
03
Conditions
cervical spinal cord injury
Beyond the preview
Go deeper on 2014-002170-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002170-36.